This study reviewed the use of continuous flow centrifugation for therapeutic plasmapheresis at Auckland Hospital over three years. A total of 26 patients received 260 procedures, primarily for dysproteinaemias and Goodpasture's syndrome. The findings suggest that this method is a feasible and frequently used approach in clinical practice. The study highlights the importance of tracking procedural data and proposes further research to confirm long-term outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Therapeutic plasmapheresis is a well-established procedure for removing harmful proteins from the blood. Prior research has shown its use in treating conditions like dysproteinaemias and autoimmune disorders. However, the specific application of continuous flow centrifugation remains less documented. No prior work had resolved the long-term outcomes of this technique in a clinical setting. This gap motivated a detailed review of clinical experiences. The study aimed to address uncertainties about procedural frequency and patient outcomes. No prior work had resolved the procedural frequency in a three-year span. The researchers sought to clarify the role of continuous flow centrifugation in plasmapheresis.
Purpose Of The Study:
The purpose of the study was to evaluate the clinical application of continuous flow centrifugation for therapeutic plasmapheresis. The researchers aimed to document the number of procedures performed and the patient conditions treated. They focused on a three-year period at Auckland Hospital. The study sought to identify the most common indications for the procedure. The goal was to assess the feasibility and frequency of this method. The researchers aimed to provide data on patient numbers and treatment duration. They wanted to highlight the relevance of this technique in managing specific diseases. The study aimed to contribute to the understanding of plasmapheresis in clinical practice.
The study found that 26 patients underwent 260 procedures, suggesting frequent use in treating dysproteinaemias and Goodpasture's syndrome.
The majority of patients had dysproteinaemias or Goodpasture's syndrome, indicating these as primary indications for the procedure.
The researchers selected a three-year period to evaluate long-term procedural frequency and clinical outcomes.
The study suggests that this method is a viable and frequently used technique for therapeutic plasmapheresis.
Main Methods:
The study involved a retrospective review of clinical records from Auckland Hospital. The researchers analyzed data collected over a three-year period from August 1975. They focused on patients who underwent continuous flow centrifugation. The primary data sources were patient medical records and treatment logs. The researchers categorized patients based on their diagnosed conditions. They recorded the total number of procedures performed and patient outcomes. The study design allowed for tracking procedural frequency and indications. The analysis included both quantitative and qualitative assessments of treatment data.
Main Results:
The study found that 26 patients received a total of 260 therapeutic procedures. Most patients had dysproteinaemias or Goodpasture's syndrome. The average number of procedures per patient was approximately ten. The data showed a consistent use of the technique over the three-year period. No significant adverse events were reported in the records reviewed. The findings suggest that continuous flow centrifugation is a viable method. The results indicate a high procedural frequency in managing these conditions. The study highlights the potential of this technique in clinical hematology.
Conclusions:
The authors concluded that continuous flow centrifugation is a feasible method for plasmapheresis. The study suggests that this technique is frequently used in treating specific conditions. The findings indicate a high procedural frequency without major complications. The authors propose that this method is suitable for managing dysproteinaemias and Goodpasture's syndrome. The study highlights the importance of tracking procedural data in clinical practice. The authors suggest that further research is needed to confirm long-term outcomes. The results may inform future guidelines on plasmapheresis techniques. The study provides evidence supporting the use of continuous flow centrifugation in clinical settings.
The average number of procedures per patient was approximately ten, based on the data collected.
The authors suggest that further research is needed to confirm long-term outcomes and procedural safety.